Industry Focus

In this episode, we look at the bank earnings (so far) and learn about person-to-person payment platform Zelle. In the latest edition of our Between Two Fools interview series, Fool.com contributor Matt Frankel, CFP sits down with Lou Anne Alexander, Group President of Payments for Early Warning, the company behind person-to-person payment platform Zelle. Later, Frankel and Industry Focus: Financials host Jason Moser discuss earnings from JPMorgan Chase (NYSE: JPM), and both tell listeners about the stocks on their radar this week. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

Soon-to-be-public Zoom is a Unicorn among Unicorns -- the company grew its top line over 100% last year and it managed to post a profit. We run through the company prospectus and see whether it is worth investing in ahead up its public debut: Stocks: ZM Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

4 years ago, Dow and DuPont merged, creating one of the world’s largest industrial conglomerates. From the start, the plan was to break this newly formed company into 3 separate businesses, each more streamlined and nimble than the combined entity. In early April, the first stage of the breakup took place when New Dow began trading. Motley Fool Contributor Lou Whiteman and Industry Focus host Nick Sciple break down each of the newly formed companies and discuss how investors should be viewing them as they come to market. Stocks Mentioned: DWDP, DOW Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

Here's why a $1 billion deal with Regeneron failed to spark a rally in Alnylam shares. Also, will genetic discovery be our generation's biggest trend? If so, Illumina, bluebird bio, and Invitae could be top stocks to watch. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

WWE stock is up over 5X in the last three years, making it one of the better performing stocks on the market. With sports licensing fees surging, the company recently negotiated a new deal that should position the company to thrive over the next several years. Dan “Pretty Boy” Kline and Nick “Hundred Dollar Man” Sciple break down how the company makes money, recent criticism surrounding the company, and the company’s future on this week’s episode. Stay tuned till the end to hear our Mount Rushmore of the greatest wrestlers of all time, our favorite highlights from Sunday’s Wrestlemania, and more! Stocks Mentioned: WWE, FOX, FOXA, CMCSA Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

Here’s the latest from around the financial sector, and an interview with a Fool.com contributor with a unique perspective on financial crimes. In this episode of Industry Focus: Financials, host Jason Moser sits down with Fool.com contributor Matt Cochrane, who happens to have a unique day job related to the financial sector. Also, regular guest Matt Frankel, CFP discusses why JPMorgan Chase (NYSE: JPM) CEO Jamie Dimon thinks America’s economic growth isn’t nearly as robust as it could be, and answers a listener question about stock buybacks. Finally, as always, Moser and Frankel each reveal what stocks they’re watching right now. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

We tackle a listener question on today's show -- why should I care about EBITDA? Listen in to get a breakdown of the metric, how it can be used for good, and how it can be abused by businesses trying to mask bad results. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

A second crash of Boeing’s 737 Max has shaken the airline industry over the past month. As the world’s largest operator of 737 aircraft, Southwest Airlines has been particularly affected. Motley Fool contributor Adam Levine-Weinberg and Industry Focus host Nick Sciple break down how Southwest is adapting to the 737 Max news, discuss the company's' newest routes to Hawaii, and take a look at whether the stock might be a buy today. Stocks Mentioned: LUV, HII, BRK-A, BRK-B Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter Thanks to Grammarly for supporting Industry Focus. For 20% off a Grammarly premium account, go to Grammarly.com/fool.

Technology has invaded every sector of the market, including healthcare. In this weeks episode of Industry Focus: Healthcare, host Shannon Jones and fool.com contributor Brian Feroldi discuss 5 hybrid healthcare/tech stocks that should be on your radar. Stocks mentioned: VEEV, HQY, TDOC, MDSO, CERN Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

McDonald's invests in its customer experience and Whole Foods is lowering prices (again). On this week’s episode of Industry Focus: Consumer Goods host Jason Moser and Fool.com contributor Asit Sharma discuss how the fast-food giant is leaning on technology as well as Amazon's long-term strategy with Whole Foods. Plus Jason chats with Aaron Timmons to learn more about his career with Amazon in a new installment of Between Two Fools. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

In this episode of Industry Focus: Financials, host Jason Moser sits down with Amalgamated Bank (NASDAQ: AMAL) CEO Keith Mestrich to talk about the opportunities and challenges of operating a smaller and socially-responsible bank in the modern financial landscape. Plus, Fool.com contributor Matt Frankel, CFP discusses what Wells Fargo (NYSE: WFC) CEO Tim Sloan’s abrupt departure could mean for the bank and its investors. And, you’ll hear which two stocks we’re watching this week. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter Thanks to Grammarly for supporting The Motley Fool. For 20% off a Grammarly premium account, go to http://www.Grammarly.com/Fool.

Another unicorn is going public! We take a look at Pinterest's prospectus and explain how the social media company has turned DIY pics into a $12B business. Stocks: PINS, FB, GOOG, GOOGL Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

On March 8, 2018, the United States enacted 25% tariffs on imported steel. A year later, have those tariffs accomplished what they set out to do? Motley Fool Contributor Jason Hall and Industry Focus host Nick Sciple answer that question and share their favorite steel investment on this week’s episode.

Biogen's shares fell 30% because it's bailing on a once-promising Alzheimer's disease drug, but it might not be a bargain worth buying yet. Also, why a shareholder revolt could cause Bristol-Myers and Celgene's merger to fall apart. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

Amazon has increased its focus on profitability and that means getting rid of items where it “can’t realized a profit” or CRaP as the company unofficially calls them. Host Shannon Jones and Fool Contributor Daniel Kline also discuss whether CVS selling CBD products fits its image as a company focused on health. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

In the latest edition of our Between Two Fools interview series, host Jason Moser sits down with Ellevest CEO and co-founder Sallie Krawckeck. Then, Fool.com contributor Matt Frankel, CFP tells investors what they need to know about the latest Federal Reserve meeting and why bank stocks have been dropping ever since. Finally, you’ll hear which two stocks are on our watch lists this week. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

Today we talk about a topic we've never covered before -- ETFs! Exchange-traded Funds are a great way for investors to get instant exposure to a basket of companies, and there are plenty of tech funds that have put up big returns over the past few years. We run through some solid options, and explain the difference between ETFs and mutual funds. Tickers: ETFMG, HACK, ARKW, FDN, VGT, XLK Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

Sometimes great companies are found in under-the-radar places. Graco is one of those companies. You probably haven’t heard of it (I thought it made baby strollers before doing my research), but this maker of industrial fluid and coating machinery has trounced Mr. Market over the past 25 years. Motley Fool Senior Analyst John Rotonti joins the podcast to discuss why this underfollowed company is an attractive investment today. Stocks Mentioned: GGG, SHW   Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

Fool's have questions, we've got answers! In today's show we offer tips on what to look for before buying clinical-stage and commercial-stage biotech stocks, including 5 checklist items you ought to know. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

It’s March Madness time as the NCAA men’s and women’s basketball tournaments are set to begin. On this week’s episode of Industry Focus: Consumer Goods host Jason Moser and Fool.com contributor Asit Sharma look at how their favorite teams made it to the Big Dance and talk about all the different ways investors can benefit from one of the year’s biggest sporting events. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter Thanks to LinkedIn for supporting The Motley Fool.  Go to Linkedin.com/fool and get $50 off your first job post.